Access to Experimental Drugs in Terminal Illness: Ethical Issues helps you understand the ethical dilemmas experienced by those suffering from terminal illnesses who are denied legal access to experimental, potentially life-saving drugs and who are then pressured into clinical tests designed to test and further the approval of those very same drugs. You'll get a better understanding of the urgent need for an ethical and legal re-evaluation of the current drug approval and drug testing process in most western countries.Access to Experimental Drugs in Terminal Illness assists you in gaining a better understanding of the changes to the drug testing and drug approval process political AIDS activism has achieved. In many ways, AIDS is a paradigmatic case for how people with terminal illnesses can make a difference to drug testing and drug approval. Specifically, you'll read about the importance of respecting the autonomy of terminally ill people who request to be given access to experimental drugs. The author gathers support for this view from a wide range of classical and contemporary moral philosophers. He also discusses the practical implications of his ethical analysis of the current regulations for drug approval and drug testing. Overall, you'll see that Access to Experimental Drugs in Terminal Illness is an innovative contribution to the current debate raging over the ethical justifiability of current clinical trials and their design. You'll find that your understanding of this debate will flourish and increase as you realize the need for improvement in the drug approval process worldwide.
Sprache
Verlagsort
Verlagsgruppe
Zielgruppe
Für höhere Schule und Studium
Für Beruf und Forschung
Gewicht
ISBN-13
978-0-7890-0563-2 (9780789005632)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Klassifikation
Autor*in
Univ Of The Witwatersrand
Contents Preface
Introduction
Autonomy--Access to Experimental Drugs and the Terminally Ill
Immanuel Kant
Weak Paternalism: John Stuart Mill
Weak Paternalism: Joel Feinberg
Weak Paternalism: Gerald Dworkin
Weak Paternalism: Ruth R. Faden, Tom L. Beauchamp, and James F. Childress
Strong Paternalism: Robert Young
The Importance of Respecting Individual Autonomy
Summary of the Philosophical Debate
Practical Implications of the Arguments Presented So Far
Should We Restrict Access to Experimental Drugs in Order to Promote Clinical Trials?
Research Clinical Trials--Are They Designed to Help Current or Future Patients?
Physicians and Patients
The History of AZT in AIDS Therapy: Examples of Ethically Problematic Clinical Trials
The Fischl/Richman AZT-trial
Table 1
Conclusion
Bibliography
Index
Reference Notes Included